Group 1 - The company held its 28th meeting of the 6th board of directors on June 23, 2025, with all seven directors present, complying with the Company Law and Articles of Association [1] - The board approved the proposal to adjust the acquisition of 34% equity stake in Guoxin Bindi from State Power Investment Corporation Binhai [2] - The acquisition involves the company and Yancheng Guoneng Investment Co., Ltd. forming a consortium to acquire the stake, with the company acquiring 26.27% and Yancheng Guoneng acquiring 7.73% [2] Group 2 - Following the acquisition, the company's shareholding in Guoxin Bindi will increase to 77.27%, requiring a capital contribution of 630.48 million yuan [2] - The board also approved the signing of performance responsibility agreements for the management team for the year 2025, aiming to clarify annual assessment targets [2]

Group 1 - The company held its 19th meeting of the 10th board of directors, which was legally valid with all 7 directors present [1] - The board approved an investment proposal for its subsidiary, Hongchang (Beijing) Venture Capital Co., Ltd., to invest RMB 39 million in Hongxing Zhixin Technology (Nanjing) Co., Ltd. [1] - Another subsidiary, Beijing Datang Gaohong Digital Technology Co., Ltd., is set to invest RMB 26 million in the same company, with a total registered capital increase of RMB 2,600 million [2] Group 2 - After the capital increase, Gaohong Digital will acquire a 3.77% stake in Hongxing Zhixin, with a total registered capital of RMB 405.04 million [2] - The investment price for the capital increase is set at RMB 2.76 per registered capital [2] - One board member opposed the proposal, citing concerns about the relationship between Hongxing Zhixin's business and the fundraising project, as well as issues regarding the employee stock ownership platform [2]

Group 1 - The company announced the establishment of a wholly-owned subsidiary, Jiangsu Huasu Hebei Technology Service Co., Ltd., with an investment of 1 million RMB by its subsidiary Shandong Huasu Health Care Products Co., Ltd. [1][4] - The investment aims to enhance the product registration process for a full range of toothpaste products and strengthen production capabilities at the Weihai production base, thereby diversifying the company's product line and revenue sources [8][10] - The investment does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations, and does not require approval from regulatory authorities [2] Group 2 - The new subsidiary will be registered in Nanjing, Jiangsu Province, with a registered capital of 1 million RMB [3] - The business scope of the new company includes technology development and consulting for daily chemicals, cosmetics, disinfectants, health products, and software development [3] - The investment aligns with the company's overall strategic planning and business layout, and is not expected to significantly impact the company's financial status or operational results for the current year [10]